Execution version printed on Deutsche Bank AG Letterhead Paper]Watson Pharmaceuticals Inc • November 2nd, 2012 • Pharmaceutical preparations
We refer to the sale and purchase agreement dated 25 April 2012 between various parties contained therein and Watson Pharma S.à r.l. (the “Purchaser”) in relation to the sale by Actavis Acquisition Debt S.à r.l. to the Purchaser of (a) all of the issued share capital of Actavis Pharma Holding 4 ehf., Actavis S.à r.l. and Actavis, Inc. and (b) the Intra Group Debt (as defined therein) (the “SPA”). Capitalised terms used in this letter but not otherwise defined shall have the meanings given to such terms in the SPA.
